TG THERAPEUTICS, INC.: net_income
| Value | {"amount": -348100000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3601d13a-2a91-4d93-9333-bb5796cb0499
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-26-014233Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/net-income/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3601d13a-2a91-4d93-9333-bb5796cb0499
History
- supersedes {"amount": -348101000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001437749-24-006144)